DTIL financials
Precision BioSciences (DTIL) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
DTIL income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $34.26M | $34.26M | -$52.15M | -$45.72M | -3.56 |
| 2024 | $68.70M | $68.70M | -$26.16M | $7.17M | 1.04 |
| 2023 | $48.73M | $48.73M | -$43.74M | -$61.32M | -15.96 |
| 2022 | $25.10M | $25.10M | -$62.31M | -$111.64M | -38.10 |
| 2021 | $115.53M | $115.53M | -$39.38M | -$30.60M | -15.60 |
| 2020 | $24.29M | $24.29M | -$109.83M | -$109.01M | -62.85 |
- DTIL revenue was $34.26M in fiscal 2025, net income -$45.72M.
Updated 2026-11-05 18:47 UTC